As leaders in topical treatments, Dechra is acutely aware of the complexities that surround the use of antibiotics and the importance of using them responsibly. To strengthen our position further, Dechra will be progressively introducing a range of SmartTab antibiotics and innovative practice support initiatives.
Guidelines for Responsible Antibiotic Use in Dogs and Cats
To help prevent the emergence of multiple drug resistant bacteria the clinician should always consider the following points:
- Rather than using antibiotics as a precaution, always ask yourself "are antibiotics really needed in this case?"
- If possible, only use antimicrobials when an infection has been documented. Ideally antimicrobial choices should be made on the results of culture and sensitivity testing, and/or cytology testing, if applicable.
- Consider other treatment options before using systemic antibiotics eg. cases of surface pyoderma can receive topical treatment.
- Using narrower spectrum antibiotics reduces the selection pressure for resistance in commensal bacteria.
- If antibiotics are not resolving an infection, the diagnosis may be incorrect or there may be an underlying disease process.
- Remember, pyrexia or leucocytes are not specific for bacterial infection.
Accurate and Flexible Dosing
SmartTabs easy double divisibility ensures accurate and flexible dosing to help avoid development of antibiotic resistance associated with under dosing.
Flavoured to Enhance Compliance
SmartTabs natural meat flavouring encourages acceptance to help ensure the full course is completed.
SmartTab Antibiotics
The introduction of Metrobactin (metronidazole) and Amoxibactin (amoxicillin) represent the next step in our commitment to improve options for treatment and promote the responsible use of antibiotics.
Metrobactin® is the first veterinary licensed metronidazole tablet for the treatment of anaerobic infection in dogs and cats. Amoxibactin® is the only flavoured double-divisible amoxicillin tablet for the treatment of skin, urinary, reproductive and airway infections in dogs and cats. Both products support our existing Clavudale® antibiotic that combines amoxicillin and clavulanic acid.
Navigation